Article Sidebar
Published:
Jul 12, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Triptolide mitigates rheumatoid arthritis through Notch1/Jagged1 pathway
Abstract
Purpose: To determine the effect of triptolide on rheumatoid arthritis, and the underlying mechanism of action.
Methods: Sixty Sprague Dawley (SD) rats were assigned to blank control, model, methotrexate, and triptolide groups (n = 15/group). A rat model of rheumatoid arthritis was established. Each group was given the corresponding treatment. Toe edema and arthritis index of rats were assessed in all the groups. Levels of IL-2, IFN-γ, TNF-α, IL-6, IL-8, and IL-10 were evaluated by enzyme-linked immunosorbent assay (ELISA).
Results: Serum levels of IL-2, IFN-γ, TNF-α, IL-6 and IL-8 were significantly higher in model rats than in blank control, while IL-10 level was significantly lower (p < 0.05). In triptolide group, serum IL-2, IFN-γ, TNF-α, IL-6 and IL-8 were significantly lower than the corresponding levels in model group, but IL-10 was significantly higher. The relative mRNA and protein concentrations of Notch1 and Jagged1 were significantly higher in model rats than in blank control rats, but significantly lower, relative to model rats.
Conclusion: Tripterygium wilfordii exerts a good therapeutic effect in the treatment of rheumatoid arthritis in rats, most likely by inhibiting the activation of Notch1/Jagged1 signal pathway. Thus, it regulates inflammation by regulating the expressions of various inflammatory cytokines, and may be potential agent for the management of rheumatoid arthritis.
